-
21
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
Published 2016-01-01“…It affects about 5–10% of women of reproductive age who typically suffer from obesity, hyperandrogenism, ovarian dysfunction, and menstrual irregularity. …”
Get full text
Article -
22
Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome
Published 2004-01-01“…The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) is a subphenotype of the polycystic ovary syndrome. …”
Get full text
Article -
23
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
Published 2012-01-01“…Phenotypes of PCOS have been described on the presence of clinical hyperandrogenism, oligoovulation and polycystic ovaries. …”
Get full text
Article -
24
Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome
Published 2021-01-01“…PCOS is characterized by anovulation, hyperandrogenism, polycystic ovaries, insulin resistance, and obesity. …”
Get full text
Article -
25
Proposal for an Educational Program for the Prevention of Complications of Polycystic Ovary Syndrome
Published 2024-01-01“…<strong>Foundation:</strong> polycystic ovary syndrome is characterized by hyperandrogenism and oligoovulation. It affects women of reproductive age and can have serious health implications. …”
Get full text
Article -
26
A Case of Successful Treatment with Unilateral Oophorectomy in a Patient with Resistant Polycystic Ovary Syndrome
Published 2020-01-01“…Typical features consist of oligo/anovulation, polycystic ovaries, and features of hyperandrogenism. Pathogenesis is multifactorial, and positive family history may have a predisposition for disease development. …”
Get full text
Article -
27
Prevalence Of Skin Manifestations In Patients With Polycystic Ovarian Syndrome
Published 2024-03-01“…Keywords: PCOS, Skin manifestations, Hyperandrogenism, Hirsutism, Acne. …”
Get full text
Article -
28
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
Published 2016-01-01“…We evaluated the effects of a therapy that combines myo-inositol (MI) and D-chiro-inositol (DCI) in young overweight women affected by polycystic ovary syndrome (PCOS), characterized by oligo- or anovulation and hyperandrogenism, correlated to insulin resistance. Methods. …”
Get full text
Article -
29
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Published 2025-01-01“…One of the major risk factors for the development of gestational diabetes mellitus is polycystic ovary syndrome, primarily due to the biochemical hyperandrogenism and metabolic issues, commonly observed in these patients. …”
Get full text
Article -
30
Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
Published 2025-01-01“…PCOS is an insulin-resistant state, which drives hyperandrogenism and anovulatory infertility. The metabolic action of metformin involves amelioration of insulin resistance, which helps to resolve hormonal and metabolic disturbances and increases ovulation, pregnancy, and live birth rates relative to placebo. …”
Get full text
Article -
31
The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy
Published 2018-01-01“…Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without compensatory hyperinsulinemia, and hyperandrogenism are very common features of the polycystic ovary syndrome phenotype. …”
Get full text
Article -
32
Ocular Surface Disease Severity in Polycystic Ovary Syndrome: is This Really Significant in Daily Life?
Published 2022-03-01“…Polycystic ovary syndrome was diagnosed when two of the following conditions were met: oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, and ultrasonographic documentation of polycystic ovaries. …”
Get full text
Article -
33
Adrenocortical Production Is Associated with Higher Levels of Luteinizing Hormone in Nonobese Women with Polycystic Ovary Syndrome
Published 2014-01-01“…Insulin resistance (IR) and ovarian and adrenal hyperandrogenism are a common finding in women with polycystic ovary syndrome (PCOS). …”
Get full text
Article -
34
Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
Published 2020-01-01“…Myo-inositol’s role in improving acne by reducing hyperandrogenism has been demonstrated in PCOS patients. …”
Get full text
Article -
35
Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential
Published 2025-02-01“…Polycystic ovary syndrome (PCOS) is a multifaceted endocrine disorder characterized by irregularities in gonadotropin secretion, hyperandrogenism, chronic anovulation, and polycystic ovarian morphology. …”
Get full text
Article -
36
The Use of Yoga in the Treatment of PCOS
Published 2025-01-01“…Symptoms include multiple ovarian cysts, hyperandrogenism (high levels of male hormones), and irregular menstrual cycles. …”
Get full text
Article -
37
Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
Published 2018-01-01“…Polycystic ovary syndrome (PCOS) is a common and significant condition associated with hyperandrogenism, infertility, low quality of life, and metabolic comorbidities. …”
Get full text
Article -
38
Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism
Published 2022-01-01“…Successful treatment of hyperandrogenism can result in improvement of glycaemic control. …”
Get full text
Article -
39
Impact of headache in women with polycystic ovary syndrome
Published 2021-12-01“…Materials and methods. 114 women with PCOS (according to the Rotterdam criteria) and 80 age-matched control women with regular menses and no clinical or biochemical hyperandrogenism or polycystic ovaries were enrolled in the study. …”
Get full text
Article -
40
Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients
Published 2023-01-01“…Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of reproductive age, whose clinical characteristics are hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovary, often accompanied by insulin resistance (IR) and metabolic abnormalities. …”
Get full text
Article